P. Farahmand

Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial

Claus‐C. Glüer, Fernando Marín, J. D. Ringe et al. · Journal of Bone and Mineral Research · 2013 · 173 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

J. D. Ringe, H. Faber, P. Farahmand et al. · Rheumatology International · 2005 · 170 citations

Medicine, Endocrinology, Orthopedic Surgery +11

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study

J. D. Ringe, P. Farahmand, H. Faber et al. · Rheumatology International · 2008 · 98 citations

Medicine, Endocrinology, Orthopedic Surgery +11

Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)

J. D. Ringe, P. Farahmand, E. Schacht et al. · Rheumatology International · 2007 · 67 citations

Medicine, Endocrinology, Pharmacotherapy +15

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

P. Farahmand, Fernando Marín, Federico Hawkins et al. · Osteoporosis International · 2013 · 46 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17